Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 96T |
|---|---|
| Brand | ProteoGenix |
| Product type | Elisa assay kits |
| Product name | HSV-1/HHV-1 gC ELISA Kit |
|---|---|
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stocks, 3-5 weeks if production is needed |
| Storage condition | 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles |
| Brand | ProteoGenix |
| Note | For research use only. |
| Immunogen | gC |
| Assay type | Quantitative |
| Detection method | Colorimetric |
| Recovery | 80-120% |
The HSV-1/HHV-1 gC ELISA Kit is a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) designed for the detection and quantification of glycoprotein C (gC) from Herpes Simplex Virus 1 (HSV-1) or Human Herpesvirus 1 (HHV-1) in various biological samples. This kit is a valuable tool for researchers and clinicians alike, providing a reliable and accurate method for studying the structure, activity, and potential therapeutic targets of these viruses.
HSV-1 and HHV-1 are members of the Herpesviridae family, which are large, enveloped viruses with a linear double-stranded DNA genome. The viral envelope contains numerous glycoproteins, including gC, which plays a crucial role in virus entry and immune evasion. gC is a type I transmembrane glycoprotein with a molecular weight of approximately 120 kDa. It is composed of three domains: an N-terminal signal sequence, a highly conserved central region, and a C-terminal domain that is variable between different strains of HSV-1 and HHV-1. The gC protein is heavily glycosylated, with up to 50% of its molecular weight consisting of carbohydrate moieties.
The gC protein of HSV-1 and HHV-1 has been shown to have multiple functions in the viral life cycle. It is involved in the initial attachment of the virus to host cells, as well as in the fusion of the viral envelope with the host cell membrane. Additionally, gC can bind to and neutralize host antibodies, allowing the virus to evade the immune response. This protein has also been implicated in the modulation of host cell signaling pathways, contributing to the pathogenesis of HSV-1 and HHV-1 infections.
The gC protein of HSV-1 and HHV-1 has been identified as a potential therapeutic target for the development of antiviral drugs. This is due to its crucial role in virus entry and immune evasion, making it an attractive target for disrupting viral replication and preventing infection. Research using the HSV-1/HHV-1 gC ELISA Kit has provided valuable insights into the structure and function of gC, aiding in the development of novel antiviral therapies.
The HSV-1/HHV-1 gC ELISA Kit is a valuable tool for researchers studying the structure and function of gC, as well as its potential as a therapeutic target. This kit allows for the quantification of gC in various biological samples, including cell lysates, serum, and tissue homogenates. It has been used in numerous studies to investigate the role of gC in virus entry, immune evasion, and pathogenesis. Additionally, the kit has been used to evaluate the efficacy of potential antiviral drugs targeting gC.
The HSV-1/HHV-1 gC ELISA Kit has a wide range of applications in both research and clinical settings. It can be used to study the structure and function of gC, as well as its potential as a therapeutic target. In clinical settings, the kit can be used for the diagnosis and monitoring of HSV-1 and HHV-1 infections, as well as for evaluating the efficacy of antiviral treatments.
The HSV-1/HHV-1 gC ELISA Kit is a highly sensitive and specific tool for the detection and quantification of gC from HSV-1 and HHV-1. Its use in research has provided valuable insights into the structure, activity, and potential therapeutic targets of these
Send us a message from the form below
Reviews
There are no reviews yet.